Skip to main content
Premium Trial:

Request an Annual Quote

'Heaven Knows What'

Forbes contributor Ted Greenwald envisions a promising future for synthetic genomics. As "commercial labs are redesigning industrial organisms such as yeast," while "students in MIT's synthetic biology program are coding microbes using Lego-style biological components known as BioBricks, and DIY clubs are doing heaven knows what," Greenwald says he expects it won't be long before researchers are using genomics to engineer, among other things, "algae that produce carbon-neutral fuel. Bugs that filter polluted water. A new generation of biodegradeable materials. Crops that thrive in salty, dry, or flooded soil."

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.